UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Boosted by Fulton Breakefield Broenniman LLC

Fulton Breakefield Broenniman LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 64,282 shares of the healthcare conglomerate’s stock after purchasing an additional 112 shares during the period. UnitedHealth Group comprises approximately 2.7% of Fulton Breakefield Broenniman LLC’s holdings, making the stock its 8th largest holding. Fulton Breakefield Broenniman LLC’s holdings in UnitedHealth Group were worth $33,843,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Robbins Farley bought a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $25,000. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC increased its stake in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC boosted its stake in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on UNH shares. Bank of America reiterated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Wells Fargo & Company decreased their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Up 0.3 %

UNH opened at $495.35 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm’s 50 day simple moving average is $485.84 and its two-hundred day simple moving average is $514.14. The company has a market capitalization of $455.76 billion, a PE ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter last year, the company earned $6.26 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is 45.97%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.